PUBLISHER: GlobalData | PRODUCT CODE: 1535051
PUBLISHER: GlobalData | PRODUCT CODE: 1535051
Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR). Mitral regurgitation (MR), also known as mitral insufficiency, is caused by insufficient systolic coaptation of the mitral valve leaflets along with a change in the pressure gradient between the atrium and left ventricle. There are two types of MR: degenerative (primary), and functional (secondary). In Europe, transcatheter mitral valve repair (TMVR) is indicated for both primary and secondary MR. Transcatheter Mitral Valve Repair (TMVR) is FDA approved for both primary and secondary MR. Mitral valve repair treatment is preferred over mitral valve replacement in eligible patients because it is linked with lower short-term and long-term mortality and morbidity rates.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -